Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2008 by Wayne State University.
Recruitment status was:  Recruiting
Information provided by:
Wayne State University Identifier:
First received: November 12, 2008
Last updated: NA
Last verified: October 2008
History: No changes posted
The purpose of this study is to see the effect of Januvia on Ghrelin levels in patients with diabetes.

Type 2 Diabetes

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes

Resource links provided by NLM:

Further study details as provided by Wayne State University:

Biospecimen Retention:   Samples Without DNA
Serum of patients will be kept for future studies

Estimated Enrollment: 45
Study Start Date: July 2008
Estimated Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
Patients who on Januvia
Patients on Janumet (Combination of Januvia and Metformin)
Patients on Metformin


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with type 2 diabetes on oral agent that require Metformin or Januvia only

Inclusion Criteria:

  • Patients with Type 2 diabetes

Exclusion Criteria:

  • Renal failure
  • Pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00790348

United States, Michigan
Wayne State University Recruiting
Detroit, Michigan, United States, 48201
Contact: Berhane Seyoum, MD    313-745-4008   
Principal Investigator: Berhane Seyoum, MD, MPH         
Sponsors and Collaborators
Wayne State University
  More Information

Responsible Party: Berhane Seyoum, Wayne State University Identifier: NCT00790348     History of Changes
Other Study ID Numbers: 0709005250
Study First Received: November 12, 2008
Last Updated: November 12, 2008

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Sitagliptin Phosphate
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Hypoglycemic Agents
Dipeptidyl-Peptidase IV Inhibitors
Protease Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action processed this record on May 25, 2017